NephroGenex, Inc. 4
4 · NephroGenex, Inc. · Filed Dec 15, 2014
Insider Transaction Report
Form 4
Hamill John
Chief Financial Officer
Transactions
- Award
Options to Purchase Common Stock
2014-12-12+45,000→ 45,000 totalExercise: $4.67From: 2015-12-12Exp: 2018-12-12→ Common Stock (45,000 underlying)